0001562180-24-002591.txt : 20240312
0001562180-24-002591.hdr.sgml : 20240312
20240312161927
ACCESSION NUMBER: 0001562180-24-002591
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240311
FILED AS OF DATE: 20240312
DATE AS OF CHANGE: 20240312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cavalie Fanny
CENTRAL INDEX KEY: 0001913484
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39634
FILM NUMBER: 24742330
MAIL ADDRESS:
STREET 1: C/O FOGHORN THERAPEUTICS INC.
STREET 2: 500 TECHNOLOGY SQUARE, SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foghorn Therapeutics Inc.
CENTRAL INDEX KEY: 0001822462
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-586-3100
MAIL ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-03-11
false
0001822462
Foghorn Therapeutics Inc.
FHTX
0001913484
Cavalie Fanny
500 TECHNOLOGY SQUARE
STE #700
CAMBRIDGE
MA
02139
false
true
false
false
Chief Strategy/Bus Ops Officer
false
Common Stock
2024-03-11
4
S
false
11000.00
6.5576
D
75992.00
D
This transaction was executed in multiple trades at prices ranging from $6.50 USD to $6.83 USD; the price reported above reflects the weighted average sale price.
/s/ Michael LaCascia, Attorney-in-Fact for Fanny Cavalie
2024-03-12